IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 10561 - 10570 of 12201 for "Americas" with applied filters

Deals

Arvinas NASDAQ IPO

30/8/2018

Jurisdictions

New York, United States

Practice areas

Capital markets : Equity

Industry sectors

Pharmaceuticals and life sciences

Deal types:

IPO
Deals

Asahi Kasei $2.7 billion acquisition of Polypore

26/8/2015

Jurisdictions

United States

Practice areas

M&A

Industry sectors

Pharmaceuticals and life sciences, Technology and telecommunications

Value:

$ 2.7 billion

Deal types:

Public acquisition
Deals

Ashland $2.3 billion financing

23/6/2015

Jurisdictions

United States

Practice areas

Banking

Industry sectors

Banking

Value:

$ 2.3 billion

Deal types:

Financing
Deals

Associated Materials $675 million 9% notes issue

22/11/2016

Jurisdictions

United States

Practice areas

Capital markets : Debt

Industry sectors

Industrials and manufacturing

Value:

$ 675 million

Deal types:

Investment grade bond/note issue
Deals

Assurant $1.9 billion acquisition of Warranty Group

18/10/2017

Jurisdictions

United States

Practice areas

M&A

Industry sectors

Financial services

Value:

$ 1.9 billion

Deal types:

Private acquisition
Deals

Astellas Pharma $3 billion acquisition of Audentes Therapeutics

2/12/2019

Jurisdictions

California, Japan, United States

Practice areas

M&A

Industry sectors

Pharmaceuticals and life sciences

Value:

$ 3 billion

Deal types:

Public acquisition
Deals

AstraZeneca $4 billion acquisition of 55% stake in Acerta Pharma

17/12/2015

Jurisdictions

Netherlands, United Kingdom, United States

Practice areas

M&A

Industry sectors

Pharmaceuticals and life sciences

Value:

$ 4 billion

Deal types:

Private acquisition
Deals

AstraZeneca $2 billion 2.375% and 3.125% notes issues

13/6/2017

Jurisdictions

United States

Practice areas

Capital markets : Debt

Industry sectors

Pharmaceuticals and life sciences

Value:

$ 2 billion

Deal types:

Investment grade bond/note issue
Deals

AstraZeneca $3 billion 3.50%, 4%, 4.375%, floating rate notes issue

14/8/2018

Jurisdictions

United Kingdom, United States

Practice areas

Capital markets : Debt

Industry sectors

Pharmaceuticals and life sciences

Value:

$ 3 billion

Deal types:

Investment grade bond/note issue
Deals

AstraZeneca $6 billion notes issue

15/11/2016

Jurisdictions

United Kingdom, United States

Practice areas

Capital markets : Debt

Industry sectors

Pharmaceuticals and life sciences

Value:

$ 6 billion

Deal types:

Investment grade bond/note issue
Load more